These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 19023205
1. Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K. Digestion; 2008; 78(2-3):113-9. PubMed ID: 19023205 [Abstract] [Full Text] [Related]
2. Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T. Gastrointest Endosc; 2012 Jan; 75(1):39-46. PubMed ID: 22018552 [Abstract] [Full Text] [Related]
3. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer. Pimanov SI, Makarenko EV, Voropaeva AV, Matveenko ME, Voropaev EV. J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360 [Abstract] [Full Text] [Related]
4. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori. Haneda M, Kato M, Ishigaki S, Suzuki M, Takahashi M, Nakagawa M, Ono S, Mori Y, Mabe K, Nakagawa S, Kudo T, Shimizu Y, Asaka M. J Gastroenterol Hepatol; 2013 Jan; 28(1):78-83. PubMed ID: 23034090 [Abstract] [Full Text] [Related]
8. Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication. Hanaoka N, Uedo N, Shiotani A, Inoue T, Takeuchi Y, Higashino K, Ishihara R, Iishi H, Haruma K, Tatsuta M. J Gastroenterol Hepatol; 2010 Dec; 25(12):1844-9. PubMed ID: 21091995 [Abstract] [Full Text] [Related]
9. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay. Sun LP, Gong YH, Wang L, Gong W, Yuan Y. J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790 [Abstract] [Full Text] [Related]
11. [Investigation about usefulness of serum antibody of Helicobacter pylori and serum pepsinogen I/II ratio as a marker of the judgment after eradication therapy]. Fujisawa T, Kumagai T, Goto A, Fujimori K, Akamatsu T, Kiyosawa K. Nihon Rinsho; 1999 Jan; 57(1):101-6. PubMed ID: 10036944 [Abstract] [Full Text] [Related]
13. Role of metallothionein in Helicobacter pylori-positive gastric mucosa with or without early gastric cancer and the effect on its expression after eradication therapy. Mitani T, Shirasaka D, Aoyama N, Miki I, Morita Y, Ikehara N, Matsumoto Y, Okuno T, Toyoda M, Miyachi H, Yoshida S, Chayahara N, Hori J, Tamura T, Azuma T, Kasuga M. J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e334-9. PubMed ID: 17725597 [Abstract] [Full Text] [Related]
20. Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection. Kwon Y, Jeon S, Nam S, Shin I. Aliment Pharmacol Ther; 2017 Oct; 46(8):758-767. PubMed ID: 28799258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]